PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2011 2012
FIND aims to strengthen the quality of laboratory services, introduce new and more rapid diagnostic tools, increase human resource capacity and support the integration of laboratory services for diagnostic testing of tuberculosis (TB), and HIV. FIND will support the National Health Laboratory Services NHLS South Africa to continue the roll out of the Xpert MTV/Rif (Cepheid) new test, recently endorsed by WHO, at an additional five high burden testing sites along with an appropriate EQA scheme at all already established testing sites. A recent study revealed variable compliance with some of the steps involved, ranging from patient verification (for TB sputum testing), to proper testing procedures, particularly with respect to biosafety (wearing gloves TB and HIV specimen collection), to reporting, and to referral back to the health care provider (HIV testing). The causes for non-compliance as identified in the study include: lack of training, lack of supplies (blood HIV testing and folders/registers TB), and deliberate staff error (not wearing gloves). Rectifying these issues will require a multifaceted approach including: i) review of training and training refresher procedures and materials; ii) record-keeping/administrative procedures (e.g. examining whether these could be simplified or automated to facilitate compliance); and iii) logistics (to ensure needed items are in stock).Working with the NHLS and the CDC, FIND will first identify activities that can be prioritized.. Procedures for monitoring to ensure process compliance, and quality improvement activities will be designed and implemented.
FIND will facilitate the implementation of Xpert/Rif testing at 5 high burden testing sites with training equipment and reagents with two technicians to be trained per site with the assay. FIND will also facilitate the wider roll-out and EQA of the Xpert/Rif assay for of rapid detection of drug resistant TB . This will include the development and piloting of an EQA scheme, building on the work already done by NHLS, the development of a computer-based monitoring system for Xpert/RIF which will support EQA, as well as system monitoring to provide timely feedback on quality indicators, corrective actions, testing capacity and benchmarking of testing sites.This will be planned to cover 10 sites in COP11, and in COP12, FIND will continue to support the NHLS with the phased implementation of the system to all testing sites. FIND will also assist the NHLS with revisions of training materials and SOPs for Xpert/Rif. In order to strengthen the clinical laboratory interface in the country FIND will work on the development of a mobile phone based system and software that will support improved processes for specimen collection, tracking and transportation. This will be linked to the in-built capacity of the Xpert device. In order to strengthen the clinical laboratory interface in the country FIND proposes to work on the development of a mobile phone based logistics improvement system and software. Improving the pre-analytic and post-analytic phases of laboratory services. FIND will work with NHLS and CDC to identify key areas , such as improving processes, redesigning recording requirements and forms, and providing selected trainings. Throughout all these activities, FIND will build on existing systems and work already done by the NHLS. In all these areas, FIND will carefully evaluate the current systems, and consult closely with NHLS and CDC.
